The American Medical Association now offers ethical guidance to physicians who are considering selling their private ...

E-bikes are not a transportation story that happens to involve health. They are a health story that happens to involve ...

The question is not how clinicians can be made more resilient. It is why an institution performing at the highest level of ...

Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more ...

The Trump administration has aggressively sought to restructure the federal health system using funding. Lower courts have repeatedly voided the administration’s actions, but the Supreme Court has ...

Perhaps the term “better” should not be defined by business metrics at all—but instead by the innovation’s health impacts ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...

Rather than impose one-size-fits-all solutions, federal and state policy makers should craft Medicaid payment policies that ...

California cannot control whether mifepristone will remain available at the national level. But it can control whether ...

Nasal naloxone remains expensive relative to the cost of the underlying drug and continues to strain budgets of public health ...

Congress should require the FDA to make DSCSA traceability data accessible and interpretable not only by regulatory agencies ...

If an HHS Secretary can seek to unilaterally overturn an evidence-based standard of transgender health care, the same can ...